Chemistry: analytical and immunological testing – Cancer
Reexamination Certificate
2001-12-26
2010-10-26
Harris, Alana M. (Department: 1643)
Chemistry: analytical and immunological testing
Cancer
C436S063000, C436S501000, C436S503000, C436S813000, C435S004000, C435S007100
Reexamination Certificate
active
07820447
ABSTRACT:
The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially lymphoma carcinomas. In addition, the present invention describes the use of novel compositions for use in screening methods.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4301144 (1981-11-01), Iwashita et al.
patent: 4469863 (1984-09-01), Ts'o et al.
patent: 4496689 (1985-01-01), Mitra
patent: 4640835 (1987-02-01), Shimizu et al.
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4791192 (1988-12-01), Nakagawa et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5124246 (1992-06-01), Urdea et al.
patent: 5216141 (1993-06-01), Benner
patent: 5235033 (1993-08-01), Summerton et al.
patent: 5359100 (1994-10-01), Urdea et al.
patent: 5386023 (1995-01-01), Sanghvi et al.
patent: 5445934 (1995-08-01), Fodor et al.
patent: 5545730 (1996-08-01), Urdea et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5571670 (1996-11-01), Urdea et al.
patent: 5580731 (1996-12-01), Chang et al.
patent: 5591584 (1997-01-01), Chang et al.
patent: 5594117 (1997-01-01), Urdea et al.
patent: 5594118 (1997-01-01), Urdea et al.
patent: 5597909 (1997-01-01), Urdea et al.
patent: 5602240 (1997-02-01), De Mesmaeker et al.
patent: 5624802 (1997-04-01), Urdea et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5635352 (1997-06-01), Urdea et al.
patent: 5637684 (1997-06-01), Cook et al.
patent: 5644048 (1997-07-01), Yau
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5681697 (1997-10-01), Urdea et al.
patent: 5681702 (1997-10-01), Collins et al.
patent: 5700637 (1997-12-01), Southern
patent: 5759776 (1998-06-01), Smith et al.
patent: 5776683 (1998-07-01), Smith et al.
patent: 5928870 (1999-07-01), Lapidus et al.
patent: 6074825 (2000-06-01), Rundell et al.
patent: 6153441 (2000-11-01), Appelbaum et al.
patent: 6812339 (2004-11-01), Venter et al.
patent: 2003/0143539 (2003-07-01), Bertucci et al.
patent: WO 87/05330 (1987-09-01), None
patent: WO 90/10448 (1990-09-01), None
patent: WO 91/04753 (1991-04-01), None
patent: WO 95/25116 (1995-09-01), None
patent: WO 95/35505 (1995-12-01), None
patent: WO 97/27212 (1997-07-01), None
patent: WO 97/27213 (1997-07-01), None
patent: WO 01/94629 (2001-12-01), None
patent: WO 02/22660 (2002-03-01), None
patent: WO 02/46467 (2002-06-01), None
patent: WO 03/008583 (2003-01-01), None
patent: WO 03/053224 (2003-07-01), None
Muramatsu, T. et al. Biochemical and Biophysical Research Communications, 188: 265-271, 1992.
Tockman, M.S. et al. Cancer Research, (Suppl.) 57: 2711s-2718s, 1992.
Lakshmikuttyamma, A. et al., Journal of Cellular Biochemistry 95: 731-739, 2005.
Kihara, H. et al, International Journal Oncology 12: 629-634, 1998.
Padma, S. et al, Clinica Chimica Acta, 321: 17-21, 2002.
Yamamoto, M. et al. Leukemia, 13: 595-600, 1999.
McClean and Hill, Eur J of Cancer, 1993, vol. 29A, pp. 2243-2248.
Fu et al, EMBO Journal, 1996, vol. 15, pp. 4392-4401.
McGarrity, T.J. et al., Gut, 32: 1121-1126, 1991.
Billingsley, M.L. et al., Proc. Natl. Acad. Sci., USA, 82: 7585-7589, 1985.
Mondragon, A. , et al, Biochemistry, 36: 4934-4942, 1997.
Altschul, S. F. and Gish, W. (1996). “Local Alignment Statistics” InMethods in Enzymologyvol. 266. Academic Press, Inc., pp. 460-480.
Altschul, S. F. et al. (1990). “Basic Local Alignment Search Tool,”J. Mol. Biol. 215:403-410.
Aplin, J. D. and Wriston, Jr., J. C. (1981). “Preparation, Properties, and Applications of Carbohydrate Conjugates of Proteins and Lipids,”LA Crit. Rev. Biochem. pp. 259-306.
Arenberg, D. A. et al. (2001). “The Murine CC Chemokine, 6C-Kine, Inhibits Tumor Growth and Angiogenesis in a Human Lung Cancer SCID Mouse Model,”Cancer Immunol. Immunother49:587-592.
Ausubel, F. M. et al., eds. (1992).Short Protocols in Molecular Biology. Greene Publishing Associates and John Wiley & Sons, pp. iii-xviii (Table of Contents Only).
Beaucage, S. L. and Iyer, R. P. (1993). “The Functionalization of Oligonucleotides Via Phosphoramidite Derivatives,”Tetrahedron49(10):1925-1963.
Boener, P. et al. (1991). “Production of Antigen-Specific Human Monoclonal Antibodies from in Vitro-Primed Human Splenocytes,”J. Immunol. 147(1):86-95.
Bolli. M. et al. (1994). “α-Bicyclo-DNA: Synthesis, Characterization, and Pairing Properties of α-DNA-Analogues with Restricted Conformational Flexibility in the Sugar-Phosphate Backbone,” Chapter 7 InCarbohydrate Modifications in Antisense Research. Shanghvi, Y. S and Cook, P. D, eds, American Chemical Society, Washington, pp. 100-117.
Brill et al. (1989). “Synthesis of Oligodeoxynucleoside Phosphoridithioates via Thioamidites,”J. Am Chem soc. 111:2321-2322.
Brower, V. (1998). “New German Government Muddies the Biotech Waters,”Nature Biotechnology16:1304-1305.
Carlsson, C. et al. (1996). “Screening for Genetic Mutations,”Nature380:207 (1 page total).
Cole, S.P.C., et al. (1985). “The EBV-Hybridoma Technique and Its Application to Human Lung Cancer,” InMonoclonal Antibodies and Cancer Therapy, Reisfeld, R. A. and Sell, S., ed., Alan R. Liss, New York, p. 77-96 (Includes Table of Contents).
Creighton, T. E., ed. (1983). “Posttranslational Covalent Modifications of Polypeptide Chains,” Chapter 2 InProteins: Structure and Molecular Properties. W. H. Freeman & Co., San Francisco. pp. 79-86 (Includes Table of Contents).
David, G. S. and Reisfeld, R. A. (1974). “Protein Iodination with Solid State Lactoperoxidase,”Biochemistry13(5):1014-1021.
De Mesmaeker, A. et al. (1994). “Comparison of Rigid and Flexible Backbones in Antisene Oligonucleotides,” Biooroganic & Medicianl Chem. Lett. 4(3):395-398.
De Mesmaeker, A. et al. (1994). “Novel Backbone Replacements for Oligonucleotides,” Chapter 2 InCarbohydrate Modifications in Antisense Research. Shanghvi, Y. S and Cook, P. D, eds, American Chemical Society, Washington, pp. 24-39.
Dempcy, R. O. et al. (1995). “Synthesis of a Thymidyl Pentamer of Deoxyribonucleic Guanidine and Binding Studies with DNA Homopolynucleotides,”Proc. Natl Acad. Sci. USA92:6097-6101.
Devereux et al. (1984). “A Comprehensive Set of Sequence Analysis Programs for the VAX,”Nuc. Acid. Res. 12(1):387-395.
Doudney, K. et al. (2001). “Comparative Physical and Transcript Maps of˜ 1 Mb aroundlooptail, a Gene for Severe Neural Tube Defects on Distal Mouse Chromosome 1 and Human Chromosome 1q22-q23,”Genomics72(2):180-192.
Eckstein. F., ed. (1991).Oligonucleotides and Analogues: A Practical Approach, Oxford University Press, vii-xvii. (Table of Contents Only).
Edge, A. S. B. et al. (1981). “Deglycosylation of Glycoproteins by Trifluoromerathneusulfonic Acid,”Anal. Biochem. 118:131-137.
Elgholm, M. (1993). “PNA Hybridizes to Complementary Oligonucleotides Obeying the Watson-Crick Hydrogenbonding,”Nature365:566-568.
Elgholm, M. et al. (1992). “Peptide Nucleic Acids (PNA). Oligonucleotide Analogues with an Achiral Peptide Backbone,”J. Am. Chem. Soc. 114:1895-1897.
Evan, G. I. et al. (1985). “Isolation of Monoclonal Antibodies Specific for Human c-myc Proto-Oncogene Product,”Biology5(12):3610-3616.
Fan, L. et al. (2000). “Cutting Edge: Ectopic Expression of the Chemokine TCA4/SLC is Sufficient to Trigger Lymphoid Neogenesis,”J. Immunol. 164(8):3955-3959.
Feng, D. F. & Doolittle, R. F. (1987). “Progressive Sequence Alignment as a Prerequisite to Correct Phylogenetic Trees,”J. Mol. Evol. 35:351-360.
Field, J. et al. (1988). “Purification of a RAS-Responsive Adenylyl Cyclase Complex fromSaccharomyces cerevisiaeby Use of a Epitope Addition Method,”Mol Cell. Biol. 8(5):2159-2165.
Fishwild, D. M.et al. (1996). “H
Engelhard Eric K.
Morris David W.
Alexander Lisa E.
Gay David
Harris Alana M.
Holleran Anne L
Sagres Discovery Inc.
LandOfFree
Compositions and methods for cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4197738